Vitamin C and Emerging Research on Cancer Biology
(Educational only — not medical advice)
A number of early studies suggested that vitamin C may influence tumor biology, particularly through its antioxidant effects.
An animal study published in the American Journal of Clinical Nutrition (1991;54:1256S–60S) found that vitamin C inhibited estrogen-induced kidney tumors. Earlier, the Journal of the National Cancer Institute (1990;82:561–569) reported an inverse association between vitamin C intake and breast cancer risk.
Interest in vitamin C as a possible adjunctive therapy grew during the 1990 National Cancer Institute symposium, where 40 papers were presented describing potential benefits of vitamin C for cancer patients. Several animal and laboratory studies from that era also showed inhibitory effects of vitamin C on tumor growth. In some European clinics, intravenous (IV) vitamin C has been used—especially in Germany—as supportive care for patients with certain cancers, including adenocarcinoma.
Vitamin C’s biological activity goes beyond its antioxidant role.
Research has shown that vitamin C:
-
Protects cellular DNA from oxidative stress.
Biological Chemistry (2002;277(19):16895–16899) demonstrated that vitamin C helped prevent mutations in cells exposed to oxidative stress. -
Supports DNA repair pathways.
FEBS Letters (1998;363:363–367) showed that vitamin C participates in DNA repair mechanisms. -
Enhances natural killer (NK) cell activity.
According to a study in Nutrition Research (1993;13:753–764), vitamin C increased NK-cell function—important for immune surveillance.
While much of this research comes from animal models, cell studies, or small human trials, the findings have been intriguing enough to generate ongoing interest worldwide. Vitamin C is inexpensive, widely available, and plays well-understood roles in antioxidant defense and immune health—factors that continue to make it a topic of scientific investigation in cancer research.
